These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38101486)

  • 1. Impact of Apolipoprotein E Genotype on Neurocognitive Function in Patients With Brain Metastases: An Analysis of NRG Oncology's RTOG 0614.
    Wefel JS; Deshmukh S; Brown PD; Grosshans DR; Sulman EP; Cerhan JH; Mehta MP; Khuntia D; Shi W; Mishra MV; Suh JH; Laack NN; Chen Y; Curtis AA; Laba JM; Elsayed A; Thakrar A; Pugh SL; Bruner DW
    Int J Radiat Oncol Biol Phys; 2024 Jul; 119(3):846-857. PubMed ID: 38101486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.
    Brown PD; Gondi V; Pugh S; Tome WA; Wefel JS; Armstrong TS; Bovi JA; Robinson C; Konski A; Khuntia D; Grosshans D; Benzinger TLS; Bruner D; Gilbert MR; Roberge D; Kundapur V; Devisetty K; Shah S; Usuki K; Anderson BM; Stea B; Yoon H; Li J; Laack NN; Kruser TJ; Chmura SJ; Shi W; Deshmukh S; Mehta MP; Kachnic LA;
    J Clin Oncol; 2020 Apr; 38(10):1019-1029. PubMed ID: 32058845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained Preservation of Cognition and Prevention of Patient-Reported Symptoms With Hippocampal Avoidance During Whole-Brain Radiation Therapy for Brain Metastases: Final Results of NRG Oncology CC001.
    Gondi V; Deshmukh S; Brown PD; Wefel JS; Armstrong TS; Tome WA; Gilbert MR; Konski A; Robinson CG; Bovi JA; Benzinger TLS; Roberge D; Kundapur V; Kaufman I; Shah S; Usuki KY; Baschnagel AM; Mehta MP; Kachnic LA
    Int J Radiat Oncol Biol Phys; 2023 Nov; 117(3):571-580. PubMed ID: 37150264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.
    Chang EL; Wefel JS; Hess KR; Allen PK; Lang FF; Kornguth DG; Arbuckle RB; Swint JM; Shiu AS; Maor MH; Meyers CA
    Lancet Oncol; 2009 Nov; 10(11):1037-44. PubMed ID: 19801201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) - a phase II prospective randomized multicenter trial (NOA-14, ARO 2015-3, DKTK-ROG).
    Grosu AL; Frings L; Bentsalo I; Oehlke O; Brenner F; Bilger A; Fennell JT; Rothe T; Schneider-Fuchs S; Graf E; Schmoor C; Beck J; Becker G; Bock M; Egger K; Urbach H; Lahmann C; Popp I
    BMC Cancer; 2020 Jun; 20(1):532. PubMed ID: 32513138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Affecting the Baseline and Post-Treatment Scores on the Hopkins Verbal Learning Test-Revised Japanese Version before and after Whole-Brain Radiation Therapy.
    Saito H; Tanaka K; Kanemoto A; Nakano T; Abe E; Aoyama H
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: a phase II blinded randomized trial.
    Yang WC; Chen YF; Yang CC; Wu PF; Chan HM; Chen JL; Chen GY; Cheng JC; Kuo SH; Hsu FM
    Neuro Oncol; 2021 Mar; 23(3):478-486. PubMed ID: 32789503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele.
    Caselli RJ; Reiman EM; Osborne D; Hentz JG; Baxter LC; Hernandez JL; Alexander GG
    Neurology; 2004 Jun; 62(11):1990-5. PubMed ID: 15184602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hippocampal-sparing radiotherapy and neurocognitive impairment: A systematic literature review.
    Giuseppe ZR; Silvia C; Eleonora F; Gabriella M; Marica F; Silvia C; Mario B; Francesco D; Savino C; Milly B; Frezza GP; Maurizio Z; Morganti AG
    J Cancer Res Ther; 2020; 16(6):1215-1222. PubMed ID: 33342776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis.
    Li J; Bentzen SM; Li J; Renschler M; Mehta MP
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):64-70. PubMed ID: 18406884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial.
    Brown PD; Pugh S; Laack NN; Wefel JS; Khuntia D; Meyers C; Choucair A; Fox S; Suh JH; Roberge D; Kavadi V; Bentzen SM; Mehta MP; Watkins-Bruner D;
    Neuro Oncol; 2013 Oct; 15(10):1429-37. PubMed ID: 23956241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial.
    Gondi V; Pugh SL; Tome WA; Caine C; Corn B; Kanner A; Rowley H; Kundapur V; DeNittis A; Greenspoon JN; Konski AA; Bauman GS; Shah S; Shi W; Wendland M; Kachnic L; Mehta MP
    J Clin Oncol; 2014 Dec; 32(34):3810-6. PubMed ID: 25349290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastases.
    Deng X; Zheng Z; Lin B; Su H; Chen H; Fei S; Fei Z; Zhao L; Jin X; Xie CY
    BMC Cancer; 2017 Jan; 17(1):42. PubMed ID: 28068937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment Volume of MRI-Determined White Matter Injury Predicts Neurocognitive Decline After Hippocampal Avoidant Whole-Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology Radiation Therapy Oncology Group 0933.
    Bovi JA; Pugh SL; Sabsevitz D; Robinson CG; Paulson E; Mehta MP; Gondi V; Kundapur V; Shahin MS; Chao ST; Machtay M; DeNittis AS; Laack NN; Greenspoon JN; Moore KN; Huang J; Dominello MM; Kachnic LA
    Adv Radiat Oncol; 2019; 4(4):579-586. PubMed ID: 31673651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function.
    Li J; Bentzen SM; Renschler M; Mehta MP
    J Clin Oncol; 2007 Apr; 25(10):1260-6. PubMed ID: 17401015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between apolipoprotein E genotype and hypertension on cognitive function in older women in the Nurses' Health Study.
    Kim IY; Grodstein F; Kraft P; Curhan GC; Hughes KC; Huang H; Kang JH; Hunter DJ
    PLoS One; 2019; 14(11):e0224975. PubMed ID: 31697783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the impact of hippocampal sparing during whole brain radiotherapy on neurocognitive functions: A preliminary report of a prospective phase II study.
    Lin SY; Yang CC; Wu YM; Tseng CK; Wei KC; Chu YC; Hsieh HY; Wu TH; Pai PC; Hsu PW; Chuang CC
    Biomed J; 2015; 38(5):439-49. PubMed ID: 25994802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial.
    Brown PD; Jaeckle K; Ballman KV; Farace E; Cerhan JH; Anderson SK; Carrero XW; Barker FG; Deming R; Burri SH; Ménard C; Chung C; Stieber VW; Pollock BE; Galanis E; Buckner JC; Asher AL
    JAMA; 2016 Jul; 316(4):401-409. PubMed ID: 27458945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the heterogeneity of hippocampal avoidant whole brain radiotherapy treatment effect: A secondary analysis of NRG CC001.
    Cherng HR; Sun K; Bentzen S; Armstrong TS; Gondi V; Brown PD; Mehta M; Mishra MV
    Neuro Oncol; 2024 May; 26(5):911-921. PubMed ID: 38069666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.